Effects of rabeprazole, 20 mg, or esomeprazole, 20 mg, on 24‐h intragastric pH and serum gastrin in healthy subjects
Open Access
- 25 July 2002
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 16 (7) , 1301-1307
- https://doi.org/10.1046/j.1365-2036.2002.01292.x
Abstract
Aim : To compare the antisecretory effects of rabeprazole and esomeprazole in an open, randomized, two‐way crossover, clinical pharmacology study. Methods : Twenty‐four healthy subjects (14 men, 10 w...Keywords
This publication has 16 references indexed in Scilit:
- Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trialAlimentary Pharmacology & Therapeutics, 2000
- EsomeprazoleDrugs, 2000
- Esomeprazole provides improved acid control vs. omeprazole in patients with symptoms of gastro‐oesophageal reflux diseaseAlimentary Pharmacology & Therapeutics, 2000
- Identification of the characteristics influencing the degree of antisecretory activity of PPIsGastroenterology, 2000
- Rabeprazole, 20 mg Once Daily or 10 mg Twice Daily, Is Equivalent to Omeprazole, 20 mg Once Daily, in the Healing of Erosive Gastrooesophageal Reflux DiseaseScandinavian Journal of Gastroenterology, 2000
- Comparison of rabeprazole 20 mg versus omeprazole 20 mg in the treatment of active duodenal ulcer: a European multicentre studyAlimentary Pharmacology & Therapeutics, 1999
- Double‐blind, placebo‐controlled comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of erosive or ulcerative gastro‐oesophageal reflux diseaseAlimentary Pharmacology & Therapeutics, 1999
- A placebo‐controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24‐h intragastric acidity and plasma gastrin concentrations in young healthy male subjectsAlimentary Pharmacology & Therapeutics, 1998
- RabeprazoleDrugs, 1998
- The Gastrin HypothesisJournal of Clinical Gastroenterology, 1990